An estimated 9.6 million people in the United States live with diabetic retinopathy, a leading cause of blindness among working-age adults that often progresses without early warning signs, according to national data highlighted for Diabetes-Related Eye Disease Awareness Month.
Diabetic Retinopathy Damages Retina Vessels and Affects Screening Rates
- The Condition: Diabetic retinopathy damages small blood vessels in the retina at the back of the eye, sometimes causing blurred vision, internal bleeding, and permanent sight loss if left untreated.
- The Screening Gap: Nearly half of Medicare beneficiaries with diabetes miss their annual dilated eye exam, with screening rates dropping further in neighborhoods marked by high poverty.
- The Preventive Rule: Adults with type 2 diabetes generally need a comprehensive exam right at diagnosis, while those with type 1 diabetes should schedule their first check within five years.
Prevalence Estimates Across Age Groups
Among those patients, an estimated 1.84 million suffer from vision-threatening diabetic retinopathy. AJMC reported that while earlier national models focused strictly on adults aged 40 and older, the newer study captured younger populations as well. More than 1 in 10 individuals with diabetes under the age of 25 have developed the condition, a proportion that climbs to nearly 1 in 5 for adults between 25 and 39 years old.
Geographic and demographic disparities remain stark. Standardized rates of vision-threatening disease reached 8.7 percent among Black individuals and 7.1 percent among Hispanic individuals, compared with 3.6 percent among White individuals.
| Patient Demographic or State | Diabetic Retinopathy Metric | Source Study |
|---|---|---|
| US Adults with Diabetes | 9.6 million affected (26.4%) | JAMA Ophthalmology (via AJMC) |
| Vision-Threatening Cases | 1.84 million (5.1% of diabetes patients) | JAMA Ophthalmology (via AJMC) |
| Black Individuals with Diabetes | 8.7% vision-threatening prevalence | JAMA Ophthalmology (via AJMC) |
| Hispanic Individuals with Diabetes | 7.1% vision-threatening prevalence | JAMA Ophthalmology (via AJMC) |
Barriers in Medicare and Neighborhood Deprivation
Annual screening rates for Medicare fee-for-service beneficiaries hovered between 51.7 percent and 55.3 percent from 2016 through 2022, as published in the American Journal of Ophthalmology and covered by AJMC. AJMC said that screening adherence declines consistently as neighborhood deprivation rises. Patients residing in the most deprived communities faced a 16 percent lower likelihood of undergoing screening compared to peers in the least deprived areas, with a relative risk of 0.84.
Dr. Mark Mugavin, a board-certified ophthalmologist, pointed out practical obstacles that patients face outside the clinic walls. “Transportation challenges, appointment availability, work schedules and financial concerns can make it difficult, especially in communities with fewer specialists,” Mugavin told Vincennes Sun-Commercial.
Mugavin emphasized that routine vision checks for standard prescription lenses do not substitute for a comprehensive diabetic eye exam. “Protect your sight. Get recommended diabetic eye screenings, even when your vision seems normal,” Mugavin told Vincennes Sun-Commercial.
Autonomous AI Screening in Primary Care Settings
To bridge the screening gap, researchers continue to evaluate the integration of autonomous artificial intelligence systems during standard primary care visits. These tools analyze retinal images captured via nonmydriatic cameras and deliver immediate results without requiring an on-site eye specialist, as reported by AJMC.
A retrospective study published in npj Digital Medicine in March 2026 examined 3,745 adults with diabetes at Johns Hopkins Medicine. The AI-assisted model correlated with an increased rate of specialist eye care visits among African American patients, yielding an odds ratio of 1.15. Study authors said that the analysis was exploratory and confined to a single health system, signaling the need for broader clinical validation.
Seek Medical Evaluation for Sudden Vision Changes or Floaters
Patients who notice sudden vision changes, persistent blurriness, floaters, or dark spots should seek immediate evaluation from an ophthalmologist or optometrist, regardless of their last scheduled screening date.
Individuals diagnosed with diabetes must avoid assuming stable blood glucose readings eliminate ocular risk; retinal vascular damage can accumulate silently before symptoms manifest. Anyone exhibiting signs of diabetic retinopathy must coordinate with their healthcare team before altering exercise regimens or medication schedules that influence vascular health.
Primary care providers, eye specialists, and health plans maintain a shared responsibility to ensure timely diagnostic follow-ups, particularly for populations historically missing routine preventive appointments.
References
- American Journal of Managed Care (AJMC): 5 Things to Know About Diabetes-Related Eye Disease Awareness Month.
- JAMA Ophthalmology: National Prevalence Estimates of Diabetic Retinopathy in the United States.
- American Journal of Ophthalmology: Medicare Beneficiary Screening Rates and Neighborhood Deprivation.
